Maria Monica Gramatges, MD, PhD
- Cancer and Blood Disorders
Associate Section Chief, Oncology
Research Co-Director, Long-Term Survivor Program, Cancer and Hematology Center
Vice-Chair, Practice Standards Committee, Cancer and Hematology Center
Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine
Email: mmgramat@texaschildrens.org
Phone:
832-822-4242
Clinic
Phone:
832-824-4678
Office
Languages: English, Spanish
Office location:
6620 Main St
Houston, TX 77030
Get to know Maria Monica Gramatges, MD, PhD
Dr. Maria Monica Gramatges is the Associate Section Chief of Oncology and Research Co-Director of the Long-Term Survivor Program at Texas Children’s Cancer and Hematology Center.
Within her role in the Long-Term Survivor Program, she develops and facilitates local and national collaborative research that investigates the physical, medical, and psychosocial late effects of treatment for childhood cancer.
Dr. Gramatges serves as Chair of the Texas Children’s Cancer and Hematology Center Practice Standards Committee. The objective of this committee is to develop and establish standards of practice that are based on the available evidence for the non-research related treatment of hematological/oncological diseases, as well as for related supportive care efforts.
Her clinical interests include both leukemia and cancer survivorship.
Education
| School | Education | Degree | Year |
|---|---|---|---|
| Baylor Graduate School of Biomedical Sciences | PhD | Doctor of Philosophy, Clinical Investigation | 2015 |
| Stanford University School of Medicine | Fellowship | Pediatric Hematology Oncology | 2009 |
| Oregon Health Sciences University | Residency | Pediatrics | 2006 |
| University of Texas at Houston | Medical School | Doctor of Medicine | 2003 |
| College of William and Mary | Bachelors | Bachelor of Science, Art History | 1998 |
Organizations
| Organization Name | Role |
|---|---|
| American Society for Clinical Investigation (ASCI) | Member |
| American Society for Pediatric Hematology/Oncology (ASPHO) | Member |
| American Society of Hematology (ASH) | Member |
| Children's Oncology Group (COG) | Member; Vice-Chair, Outcomes/Late Effects Committee; Chair, Outcomes Survivorship Committee for the Children’s Oncology Group |
| International Society of Paediatric Oncology (SIOP) | Member |
Board Certification
American Board of Pediatrics - Pediatric Hematology/Oncology
Honors and awards
- 2021
-
Northwestern Mutual Award for Excellence in Childhood Cancer Survivorship, American Society of Pediatric Hematology/Oncology (ASPHO)
- 2018
-
Hyundai Hope on Wheels Scholar of Hope
- 2018
-
Golfer’s Against Cancer Award
- 2017
-
Faculty Recognition Award for Excellence in Teaching, Texas Children's Cancer and Hematology Center
- 2011
-
Fulbright and Jaworski Faculty Excellence Award in Teaching and Evaluation, Baylor College of Medicine
- 2014
-
Scholar of Excellence Award, Texas Children's Cancer and Hematology Center
- 2013
-
Mentored Research Scholar Grant, St. Baldrick’s Foundation
- 2012
-
Career Development Award, National Institutes of Health (NIH)
- 2012
-
Sponsor Summit Equipment Grant, Alex’s Lemonade Stand
- 2012
-
Chao Physician Scientist Award, Baylor College of Medicine
- 2011
-
Young Investigator Award, Alex’s Lemonade Stand
- 2010
-
American Society of Hematology (ASH) Clinical Research Training Institute
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Highlights
Key Health Outcomes of Long-Term Cancer Survivorship
Research Area:
Epidemiology (Cancer and Hematology)
Genetics and Genomics
Leukemia
The objectives of the Gramatges lab are to uncover genetic risks, such as underlying defects in telomere maintenance, that may predispose children to cancer and cancer therapy-related toxicities as well as late effects. Her research explores these associations using human samples obtained locally and in collaboration with organizations such as the Children’s Oncology Group and the Childhood Cancer Survivor Study. Of particular interest to her lab are biomarkers of aging and frailty, and how these biological factors are related to features of premature, accelerated aging observed in survivors of childhood cancer.